Literature DB >> 24726304

Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.

Bora Park1, Divya Awasthi1, Soumya R Chowdhury2, Eduard H Melief2, Kunal Kumar2, Susan E Knudson3, Richard A Slayden3, Iwao Ojima4.   

Abstract

Filamenting temperature-sensitive protein Z (FtsZ), an essential cell division protein, is a promising target for the drug discovery of new-generation antibacterial agents against various bacterial pathogens. As a part of SAR studies on benzimidazoles, we have synthesized a library of 376 novel 2,5,6-trisubstituted benzimidazoles, bearing ether or thioether linkage at the 6-position. In a preliminary HTP screening against Mtb H37Rv, 108 compounds were identified as hits at a cut off concentration of 5 μg/mL. Among those hits, 10 compounds exhibited MIC values in the range of 0.63-12.5 μg/mL. Light scattering assay and TEM analysis with the most potent compound 5a clearly indicate that its molecular target is Mtb-FtsZ. Also, the Kd of 5a with Mtb-FtsZ was determined to be 1.32 μM.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial; Benzimidazole; FtsZ; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24726304      PMCID: PMC4045703          DOI: 10.1016/j.bmc.2014.03.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  24 in total

Review 1.  Issues facing TB control (7). Multiple drug-resistant tuberculosis.

Authors:  M C Raviglione
Journal:  Scott Med J       Date:  2000-10       Impact factor: 0.729

Review 2.  Bacterial ancestry of actin and tubulin.

Authors:  F van den Ent; L Amos; J Löwe
Journal:  Curr Opin Microbiol       Date:  2001-12       Impact factor: 7.934

3.  FtsZ ring structure associated with division in Escherichia coli.

Authors:  E F Bi; J Lutkenhaus
Journal:  Nature       Date:  1991-11-14       Impact factor: 49.962

Review 4.  Therapeutic potential of FtsZ inhibition: a patent perspective.

Authors:  Divya Awasthi; Kunal Kumar; Iwao Ojima
Journal:  Expert Opin Ther Pat       Date:  2011-03-18       Impact factor: 6.674

5.  Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis.

Authors:  Richard A Slayden; Dennis L Knudson; John T Belisle
Journal:  Microbiology       Date:  2006-06       Impact factor: 2.777

6.  Asymmetric cell division in B. subtilis involves a spiral-like intermediate of the cytokinetic protein FtsZ.

Authors:  Sigal Ben-Yehuda; Richard Losick
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

7.  A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ.

Authors:  R C Reynolds; S Srivastava; L J Ross; W J Suling; E L White
Journal:  Bioorg Med Chem Lett       Date:  2004-06-21       Impact factor: 2.823

8.  2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.

Authors:  E Lucile White; William J Suling; Larry J Ross; Lainne E Seitz; Robert C Reynolds
Journal:  J Antimicrob Chemother       Date:  2002-07       Impact factor: 5.790

9.  Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery.

Authors:  Laurel Respicio; Pravin A Nair; Qing Huang; Burcu Anil; Sylvia Tracz; James J Truglio; Caroline Kisker; Daniel P Raleigh; Iwao Ojima; Dennis L Knudson; Peter J Tonge; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2008-05-13       Impact factor: 3.131

10.  SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.

Authors:  Divya Awasthi; Kunal Kumar; Susan E Knudson; Richard A Slayden; Iwao Ojima
Journal:  J Med Chem       Date:  2013-11-23       Impact factor: 7.446

View more
  7 in total

1.  Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agents.

Authors:  Krupanandan Haranahalli; Simon Tong; Saerom Kim; Monaf Awwa; Lei Chen; Susan E Knudson; Richard A Slayden; Eric Singleton; Riccardo Russo; Nancy Connell; Iwao Ojima
Journal:  RSC Med Chem       Date:  2020-10-16

Review 2.  Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.

Authors:  Krupanandan Haranahalli; Simon Tong; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2016-05-05       Impact factor: 3.641

3.  3D QSAR-based design and liquid phase combinatorial synthesis of 1,2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5H-benzimidazo[1,2-d][1,4]benzodiazepin-6(7H)-one derivatives as anti-mycobacterial agents.

Authors:  Nikum D Sitwala; Vivek K Vyas; Piyush Gedia; Kinjal Patel; Rania Bouzeyen; Saqib Kidwai; Ramandeep Singh; Manjunath D Ghate
Journal:  Medchemcomm       Date:  2019-03-22       Impact factor: 3.597

4.  Design and Synthesis of Some Novel Fluorobenzimidazoles Substituted with Structural Motifs Present in Physiologically Active Natural Products for Antitubercular Activity.

Authors:  Bangalore Nandha; Laxmivenkatesh Gurachar Nargund; Shachindra Laxmivenkatesh Nargund; Kishore Bhat
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 5.  Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review.

Authors:  Sumit Tahlan; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-08-06

6.  Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis.

Authors:  Shintaro Mikuni; Kota Kodama; Akira Sasaki; Naoki Kohira; Hideki Maki; Masaharu Munetomo; Katsumi Maenaka; Masataka Kinjo
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

Review 7.  Recent Progress in the Development of Small-Molecule FtsZ Inhibitors as Chemical Tools for the Development of Novel Antibiotics.

Authors:  Laura Carro
Journal:  Antibiotics (Basel)       Date:  2019-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.